ZEB1 and glioblastoma: To overcome the limitation of missing tumor markers for IDH-wildtype glioblastoma, we next analyzed a panel of nine patient-matched gliomasphere cell lines [12] to further test differences in ZEB1 expression within a pure population of tumor cells.